EpiPen rival to be offered free to many but high price for insurers
January 19, 2017 at 18:31 PM EST
Jan 19 (Reuters) - Privately held drugmaker Kaleo on Thursday said it would offer its Auvi-Q emergency allergy auto-injector at no cost to many consumers, but set a list price for the EpiPen rival that will be used as the benchmark cost to insurance companies at a whopping $4,500.